CDTX vs VICI · rev $1.3M vs P/E 9.3, rev $3.85B
Cidara Therapeutics Inc (CDTX) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
CDTX currently screens at market cap $6.96B. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the CDTX and VICI stock pages for the full models.
Not investment advice.